Buy Granules India, price target Rs 160: Jayesh Bhanushali
The analyst suggested a stoploss at Rs 142.

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 3794.64 Crore) operating in Pharmaceuticals sector.
Granules India Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 2053.59 Crore to Sales Value (97.86 % of Total Sales) and Other Operating Revenue which contributed Rs 44.84 Crore to Sales Value (2.13 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 699.53 Crore, up 17.51 % from last quarter Sales of Rs 595.27 Crore and up 20.43 % from last year same quarter Sales of Rs 580.87 Crore Company has reported net profit after tax of Rs 95.79 Crore in latest quarter.
The company’s top management includes Mr.Arun Rao Akinepally, Mr.Arun Sawhney, Mr.Harsha Chigurupati, Mr.K B Sankar Rao, Mr.Krishna Prasad Chigurupati, Mr.Priyanka Chigurupati, Mr.Robert George Cunard, Mrs.Uma Devi Chigurupati, Ms.Jyothi Prasad. Company has B S R & Associates LLP as its auditoRs As on 31-12-2019, the company has a total of 254,247,562 shares outstanding.
Download ET Markets APP